Individualized everolimus treatment for tuberous sclerosis-related angiomyolipoma promotes treatment adherence and response

Chung, N.K.X., Metherall, P., McCormick, J.A. et al. (2 more authors) (2022) Individualized everolimus treatment for tuberous sclerosis-related angiomyolipoma promotes treatment adherence and response. Clinical Kidney Journal. sfac037. ISSN 2048-8505

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © The Author(s) 2022. Published by Oxford University Press on behalf of the ERA. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
Keywords: angiomyolipoma; everolimus; monitoring; safety; treatment outcome; tuberous sclerosis complex
Dates:
  • Published (online): 7 February 2022
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 18 May 2022 11:08
Last Modified: 18 May 2022 11:08
Status: Published online
Publisher: Oxford University Press (OUP)
Refereed: Yes
Identification Number: https://doi.org/10.1093/ckj/sfac037
Related URLs:

Share / Export

Statistics